Literature DB >> 23135607

The early cardiovascular changes in pediatric patients with systemic lupus erythematosus.

Betul Sozeri1, Murat Deveci, Nida Dincel, Sevgi Mir.   

Abstract

BACKGROUND: In patients with systemic lupus erythematous (SLE) late-onset deaths are due to morbid cardiovascular changes (CVCs). Inflammatory and immune-mediated mechanisms are involved in promoting atherosclerosis development in SLE that is reflected in both functional and morphological changes in the cardiovascular system. The aim of our study was to determine the presence of these changes in pediatric SLE patients.
METHODS: Fifty-one consecutive patients (13 male, 38 female) with SLE and 25 healthy controls were included in the study. Arterial stiffness was assessed by carotid-femoral pulse wave velocity (PWVcf) and augmentation index (AIx), as measured by the Vicorder. Carotid intima-media thickness (cIMT) and the left ventricular mass index (LVMi) were also determined.
RESULTS: Patients with SLE, despite equivalent exposure to "traditional" cardiovascular risk factors, presented a higher mean PWVcf and AIx than controls (6.56 ± 1.45 vs. 5.29 ± 0.67 m/s, P =0.01 and 14.7 ± 8.1 vs. 9.36 ± 3.59 %, P = 0.02, respectively). SLE patients had greater values of cIMT and LVMi than controls (0.54 ± 0.06 vs. 0.35 ± 0.12 mm, P = 0.00 and 32.4 ± 10.8 vs 28.8 ± 1.5, P = 0.01, respectively). Nine patients had left ventricular hypertrophy (LVMi >38 g/m(2.7)). There was no significant difference in PWV, AIx, cIMT and LVMi values between presence of hypertension or nephritis within SLE patients. We found significant correlations between all parameters and activity scores.
CONCLUSIONS: Our results demonstrate that functional and morphological CVCs are independent of traditional risk factors in pediatric SLE patients and correlate with SLE disease activity scores in the early disease stages.

Entities:  

Mesh:

Year:  2012        PMID: 23135607     DOI: 10.1007/s00467-012-2342-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus.

Authors:  Aleksandar K Stanic; Charles M Stein; Adam C Morgan; Sergio Fazio; MacRae F Linton; Edward K Wakeland; Nancy J Olsen; Amy S Major
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Long-term prognosis and causes of death in systemic lupus erythematosus.

Authors:  Andrea Doria; Luca Iaccarino; Anna Ghirardello; Sandra Zampieri; Silvia Arienti; Piercarlo Sarzi-Puttini; Fabiola Atzeni; Antonio Piccoli; Silvano Todesco
Journal:  Am J Med       Date:  2006-08       Impact factor: 4.965

4.  Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study.

Authors:  Joseph A Vita; John F Keaney; Martin G Larson; Michelle J Keyes; Joseph M Massaro; Izabella Lipinska; Birgitta T Lehman; Shuxia Fan; Ewa Osypiuk; Peter W F Wilson; Ramachandran S Vasan; Gary F Mitchell; Emelia J Benjamin
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

Review 5.  Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis.

Authors:  Pascal N Tyrrell; Joseph Beyene; Brian M Feldman; Brian W McCrindle; Earl D Silverman; Timothy J Bradley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-11       Impact factor: 8.311

6.  Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus.

Authors:  Faith Selzer; Kim Sutton-Tyrrell; Shirley G Fitzgerald; Joan E Pratt; Russell P Tracy; Lewis H Kuller; Susan Manzi
Journal:  Arthritis Rheum       Date:  2004-01

7.  Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis.

Authors:  M Petri; C Lakatta; L Magder; D Goldman
Journal:  Am J Med       Date:  1994-03       Impact factor: 4.965

8.  High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus.

Authors:  Shin-Seok Lee; Sukhminder Singh; Kimberly Link; Michelle Petri
Journal:  Semin Arthritis Rheum       Date:  2008-01-25       Impact factor: 5.532

9.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

10.  Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus.

Authors:  Q Shang; L S Tam; E K M Li; G W K Yip; C M Yu
Journal:  Lupus       Date:  2008-12       Impact factor: 2.911

View more
  8 in total

1.  The vascular phenotype of children with systemic lupus erythematosus.

Authors:  Catherine Quinlan; Jameela Kari; Clarissa Pilkington; John Deanfield; Rukshana Shroff; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-05-23       Impact factor: 3.714

Review 2.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

3.  Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.

Authors:  Julien Hogan; Astrid Godron; Véronique Baudouin; Theresa Kwon; Jérôme Harambat; Georges Deschênes; Olivier Niel
Journal:  Pediatr Nephrol       Date:  2017-08-05       Impact factor: 3.714

4.  Association of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis.

Authors:  Yan Ding; Wang Liao; Zhuwen Yi; Wei Xiang; Xiaojie He
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 5.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

6.  Assessment of vascular function in systemic onset juvenile idiopathic arthritis.

Authors:  Betul Sozeri; Basak Yildiz Atikan; Kadriye Ozdemir; Sevgi Mir
Journal:  Clin Rheumatol       Date:  2016-04-13       Impact factor: 2.980

7.  Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus?

Authors:  Roberta Garcia Salomão; Luciana Martins de Carvalho; Clarice Izumi; Érika Silva Czernisz; José César Rosa; Sonir Roberto Rauber Antonini; Ana Carolina Bueno; Maria Olímpia Ribeiro do Vale Almada; Carolina de Almeida Coelho-Landell; Alceu Afonso Jordão; Virgínia Paes Leme Ferriani; Jacqueline Pontes Monteiro
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-09       Impact factor: 3.054

8.  Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study.

Authors:  Meredith A Atkinson; Sarah Joo; Sangeeta Sule
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.